share_log

Eiger BioPharmaceuticals | 10-K: FY2023 Annual Report

SEC announcement ·  Apr 8 17:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more